Morpholino

MO1-ahrra

ID
ZDB-MRPHLNO-100513-5
Name
MO1-ahrra
Previous Names
None
Target
Sequence
5' - ATCCTCAAGATGCCTGCTGTGTGTG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-ahrra
Phenotype
Phenotype resulting from MO1-ahrra
Phenotype of all Fish created by or utilizing MO1-ahrra
Phenotype Fish Conditions Figures
pericardium edematous, abnormal TL + MO1-ahrra standard conditions Fig. 7Fig. 8 from Jenny et al., 2009
whole organism hbbe3 expression increased amount, abnormal TL + MO1-ahrra standard conditions Fig. 3Fig. 4 from Aluru et al., 2014
heart deformed, abnormal TL + MO1-ahrra standard conditions Fig. 7 from Jenny et al., 2009
whole organism opn1sw1 expression decreased amount, abnormal TL + MO1-ahrra standard conditions Fig. 3Fig. 4 from Aluru et al., 2014
pericardium edematous, abnormal TL + MO1-ahrra chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 8 from Jenny et al., 2009
yolk edematous, abnormal TL + MO1-ahrra standard conditions Fig. 7 from Jenny et al., 2009
whole organism arr3b expression decreased amount, abnormal TL + MO1-ahrra standard conditions Fig. 3Fig. 4 from Aluru et al., 2014
whole organism arr3b expression decreased amount, abnormal TL + MO1-ahrra chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 4 from Aluru et al., 2014
whole organism pde6c expression decreased amount, abnormal TL + MO1-ahrra chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 4 from Aluru et al., 2014
whole organism hbbe3 expression increased amount, abnormal TL + MO1-ahrra chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 4 from Aluru et al., 2014
whole organism pde6ha expression decreased amount, abnormal TL + MO1-ahrra chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 4 from Aluru et al., 2014
whole organism pde6c expression decreased amount, abnormal TL + MO1-ahrra standard conditions Fig. 3Fig. 4 from Aluru et al., 2014
whole organism pde6ha expression decreased amount, abnormal TL + MO1-ahrra standard conditions Fig. 3Fig. 4 from Aluru et al., 2014
cranium malformed, abnormal TL + MO1-ahrra standard conditions Fig. 7 from Jenny et al., 2009
whole organism opn1sw1 expression decreased amount, abnormal TL + MO1-ahrra chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine Fig. 4 from Aluru et al., 2014
Citations